Arena Pharmaceuticals Inc (NASDAQ:ARNA)

4.37
Delayed Data
As of Mar 31
 -0.11 / -2.46%
Today’s Change
3.26
Today|||52-Week Range
7.22
+25.94%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues6.8M12.8M8.2M9.2M
 
 
 
 
 
Cost of Goods Sold240.5K851.5K667.0K1.4M
 
 
 
 
 
Depreciation And Amortization2.2M2.3M2.3M2.3M
 
 
 
 
 
 
Operating ExpensesGross Income4.4M9.6M5.2M5.4M
 
 
 
 
 
General Expenses27.9M35.0M31.4M35.6M
 
 
 
 
 
Research And Development21.0M27.0M24.5M27.8M
 
 
 
 
 
Total Operating Expenses30.4M38.2M34.4M39.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-23.5M-25.4M-26.2M-30.2M
 
 
 
 
 
Extraordinary Credit0.001.0M2.6M929.0K
 
 
 
 
Extraordinary Charge-110.0K0.00----
 
 
Interest Expense On Debt1.7M1.7M1.7M1.7M
 
 
 
 
 
Other Expenses111.0K33.6M14.7M-1.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-25.3M7.5M-10.7M-32.1M
 
 
 
 
 
Net Income-25.3M7.5M-10.7M-32.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS219.2M219.7M219.9M220.2M
 
 
 
 
 
Shares To Calculate EPS Diluted219.2M225.3M219.9M220.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.12$0.03-$0.05-$0.15
 
 
 
 
 
EPS Diluted-$0.12$0.03-$0.05-$0.15
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account